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specimen.1 As there is no specific cytological or 
histological pattern of sarcoidosis, the disease 
cannot be confirmed only by cytology or histol‑
ogy. The diagnosis of sarcoidosis also requires 
the exclusion of other diseases that may pres‑
ent the same cytological or histological pattern.
There are no uniformly accepted diagnos‑
tic algorithms in sarcoidosis. Several bioptic 
INTRODUCTION Sarcoidosis is a disease of un‑
known etiology, characterized by the formation 
of noncaseating granulomas in multiple organs.1,2 
In approximately 90% of patients, the mediastinal 
lymph nodes and lung parenchyma are involved.3 
The diagnosis is made on the basis of a clinical pic‑
ture and imaging, and its confirmation requires 
finding of noncaseating granulation in a biopsy 
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ABSTRACT
INTRODUCTION There are no widely accepted standards for the diagnosis of sarcoidosis.
OBJECTIVES The aim of this study was to assess the relative diagnostic yield of endobronchial ultrasound 
fine-needle aspiration (EBUS -FNA) and endoscopic ultrasound fine-needle aspiration (EUS -FNA), and to 
compare them with standard diagnostic techniques such as endobronchial biopsy (EBB), transbronchial 
lung biopsy (TBLB), transbronchial needle aspiration (TBNA), and mediastinoscopy.
PATIENTS AND METHODS This was a prospective randomized study including consecutive patients with 
clinical diagnosis of stage I or II sarcoidosis. EBB, TBLB, and TBNA were performed at baseline in all 
patients. Subsequently, patients were randomized to group A (EBUS -FNA) or group B (EUS -FNA). Next, 
a crossover control test was performed: all patients with negative results in group A underwent EUS -FNA 
and all patients with negative results in group B underwent EBUS -FNA. If sarcoidosis was not confirmed, 
mediastinoscopy was performed.
RESULTS We enrolled 106 patients, of whom 100 were available for the final analysis. The overall 
sensitivity and accuracy of standard endoscopic methods were 64% each. When analyzing each of 
the standard endoscopic methods separately, the diagnosis was confirmed with EBB in 12 patients 
(12%), with TBLB in 42 patients (42%), and with TBNA in 44 patients (44%). The sensitivity and ac-
curacy of each endosonographic technique were significantly higher than those of EBB+TBLB+TBNA 
(P = 0.0112 vs P = 0.0134).
CONCLUSIONS The sensitivity and accuracy of EBUS -FNA and EUS -FNA are significantly higher than 
those of standard endoscopic methods. Moreover, the sensitivity and accuracy of EUS -FNA tend to be 
higher than those of EBUS -FNA.
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members (PK or AS). All the above tests were per‑
formed during the same procedure.
In patients in whom these studies failed to con‑
firm the diagnosis, a second endosonography‑
‑guided bioptic technique was utilized in 
a crossover fashion (ie, EUS ‑FNA in those in 
whom EBUS ‑FNA was performed initially and 
EBUS ‑FNA in those in whom EUS ‑FNA was per‑
formed initially).
If the second endosonography ‑guided bioptic 
technique failed to confirm the diagnosis, patients 
were scheduled for mediastinoscopy.
The recruitment of participants was stopped 
after inclusion of the planned number of 100 
patients. All patients were followed for at least 
6 months.
Endoscopic examination was performed us‑
ing conscious sedation with midazolam and fen‑
tanyl, and local administration of lidocaine. For 
standard bronchoscopy, the BF 1T180 videobron‑
choscope (Olympus Medical Systems Corporation, 
Tokyo, Japan) was used.
The  TBNA biopsy was performed using 
the MW ‑122 (22 ‑gauge/13  mm) or SW ‑121 
(21 ‑gauge/15 mm) cytological needles (ConMed 
Endoscopic Technologies, Utica, New York, Unit‑
ed States) or the NA ‑411D ‑1521 (21 ‑gauge/15 mm) 
needle (Olympus Medical Systems Corporation, 
Tokyo, Japan).
For EBB and TBLB, biopsy forceps (M00515180; 
working channel diameter, 2.0 mm; jaw outer 
diameter, 1.8 mm; Boston Scientific, Marlbor‑
ough, Massachusetts, United States) were uti‑
lized. The standard technique of EBB was imple‑
mented, with 3 to 8 samples taken from abnormal 
areas of bronchial mucosa or from the carina of 
the right upper lobe or the middle lobe. In order 
to obtain tissue from the deeper part of the muco‑
sa and the submucosal layer of the bronchial wall, 
several biopsies were taken from the same place.
The site of TBLB was chosen on the basis of 
the high ‑resolution chest computed tomography; 
2 to 5 samples were taken.
Mediastinal lymph node biopsy was preceded 
by thorough ultrasound assessment of the en‑
tire mediastinum.
For the EBUS ‑FNA group, a BF ‑UC160F ‑OL8 
videobronchoscope (Olympus Medical Systems 
Corporation) with the EU ‑C60 7.5 MHz ultra‑
sound processor was used. For the biopsy, the cy‑
tological 22G/40‑mm needle (NA ‑201SX ‑4022, 
Olympus Medical Systems Corporation) was used. 
Biopsy of lymph node stations 11R, 10R, 11L 10L, 
7, 4R, and 4L was performed (FIGURE 1).
For the EUS ‑FNA, the GF ‑UCT160 ‑OL5 vid‑
eogastroscope (Olympus Medical Systems Cor‑
poration) with the EU ‑C60 7.5 MHz ultrasound 
processor was used. For biopsy, the cytological 
22G/80‑mm needle (NA ‑200H ‑8022, Olympus 
Medical Systems Corporation) was utilized. Bi‑
opsy of lymph node stations 7 and 4L was per‑
formed (FIGURE 2).
During TBNA, EBUS ‑FNA, and EUS ‑FNA, 3 to 
6 samples were obtained from each lymph node.
techniques have been used, including endobron‑
chial biopsy (EBB), transbronchial lung biopsy 
(TBLB), transbronchial needle aspiration (TBNA), 
and mediastinoscopy. Recently, endobronchial 
ultrasound fine‑needle aspiration (EBUS ‑FNA) 
and endoscopic ultrasound fine‑needle aspira‑
tion (EUS ‑FNA) have been introduced.
PATIENTS AND METHODS The study was per‑
formed in the Department of Thoracic Surgery, 
Jagiellonian University Medical College, John 
Paul II Hospital, Kraków, Poland. The study de‑
sign was approved by the Local Bioethics Commit‑
tee (79/KBL/OIL/2009). All patients received de‑
tailed information regarding the study. The pro‑
cedures, including the expected results and po‑
tential risks, were discussed with patients, and 
their informed consent was obtained.
It was a prospective randomized study includ‑
ing a consecutive group of patients with suspect‑
ed stage I or II sarcoidosis, who were referred to 
the Department of Thoracic Surgery between Oc‑
tober 2009 and May 2012.
The clinical questions of the study were: 1) 
what is the diagnostic yield of the standard bi‑
optic techniques (ie, EBB, TBLB, and TBNA) ver‑
sus the endosonography ‑guided techniques (ie, 
EBUS ‑FNA and EUS ‑FNA) in diagnosing sarcoid‑
osis, and 2) which of these 2 endosonography‑
‑guided techniques is more accurate in diagnos‑
ing sarcoidosis.
The inclusion criteria were as follows: age over 
18 years, clinical diagnosis of stage I or stage II 
sarcoidosis, and signed written informed consent. 
The exclusion criteria were lack of patient’s con‑
sent to undergo endoscopic bioptic techniques 
or mediastinoscopy, contraindications to bron‑
choscopy (eg, respiratory insufficiency or tracheal 
stenosis), coagulation disorders, and pregnancy.
Patients were randomized in a ratio of 1:1, us‑
ing a computerized random digit generator in 2 
groups. In group A, EBUS ‑FNA was performed, 
and in group B, EUS ‑FNA. In both groups, 
the standard diagnostic tests were performed 
during the same procedure, including EBB, TBLB, 
TBNA, and BACTEC Mycobacteria Growth Indica‑
tor Tube System analysis of the bronchial lavage. 
Patients were enrolled and randomized by 2 team 
FIGURE 1  
Endobronchial ultrasound 
needle aspiration of 
lymph node station 4R, 
showing the biopsy 
needle within the node 
(arrow)
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The descriptive statistics, mean and median 
values, as well as standard deviation and quar‑
tiles were used. The sensitivity of tests with 
a 95% confidence interval was determined us‑
ing the GraphPad InStat 3.05 software (GraphPad 
Software, San Diego, California, United States). 
The bootstrap method was used in StatisticaTM 
(Statsoft Inc., Tulsa, Oklahoma, United States) to 
compare the sensitivity of different tests. The lev‑
el of significance was set at a P value of 0.05 or 
lower.
RESULTS Between October 2009 and May 2012, 
106 patients were enrolled to the study. There 
were 61 men and 45 women (mean age, 38.7 years; 
range, 20–70 years). Stage I sarcoidosis was diag‑
nosed in 55 patients, and stage II, in 51 patients. 
Coughing and fatigue, which are the most com‑
mon clinical signs of sarcoidosis,1 were present in 
all patients. Ankle swelling was present in 70 pa‑
tients, and erythema nodosum—in 40.
Having performed the  standard diagnos‑
tic tests (EBB, TBNA, and TBLB), 55 patients 
were randomly allotted to group A and 51—to 
group B. The characteristics of the patients in 
both groups are presented in TABLE 1.
In group A, one patient was excluded due to 
initiation of treatment by his physician before 
the diagnosis had been confirmed (this was be‑
cause of signs of neurosarcoidosis and typical 
clinical picture). In group A, EBUS ‑FNA failed 
to establish the diagnosis in 8 patients (FIGURE 4). 
In group B, 2 patients were excluded. In one of 
them, complete remission of mediastinal lymph‑
adenopathy was found on endosonography and 
in another patient malignant cells were found 
in the lymph node sample (a diagnosis of lung 
cancer was subsequently confirmed). In group 
B, EUS ‑FNA failed to establish the diagnosis in 
8 patients. Therefore, the crossover endosono‑
graphic examination was performed in 16 pa‑
tients. Out of the 8 patients who had undergone 
the crossover EUS ‑FNA, the diagnosis was con‑
firmed in 7, while out of the 8 patients who had 
undergone the crossover EBUS ‑FNA, the diagno‑
sis was made in 2.
There were no complications related to the pro‑
cedure or anesthesia in any of the patients.
The cytological smear of the biopsy specimen 
was performed and fixed using 96% ethanol. Ad‑
ditionally, a nonfixed sample was prepared for 
the BACTEC examination. Samples from each 
lymph node station were prepared separately. 
The standard hematoxylin and eosin staining was 
used (FIGURE 3). Samples were independently re‑
viewed by 2 pathologists, who were blinded to 
the sampling method.
Mediastinoscopy was performed in the stan‑
dard fashion, under general anesthesia, using 
the Linder–Dahan mediastinoscope (Richard Wolf 
GmbH, Knittlingen, Germany). Lymph node sta‑
tions 4R, 4L, 7, and 10R were sampled.
The sample size was determined to detect 
the difference equal to 10% between 2 propor‑
tions in partially dependent samples with a sig‑
nificance level of 0.05 and a power of 0.7.
FIGURE 2 Endoscopic 
ultrasound needle 
aspiration of lymph node 
station 7, showing 
the typical pattern of 
lymph nodes with marked 
capsules (arrow)
FIGURE 3 Cytological 
smear of a lymph node 
sample in a patient with 
sarcoidosis, showing the 
groups of epithelioid cells  
typical for sarcoidosis
TABLE 1 Characteristics of patients in the study groupsa
Characteristics Group A (EBUS -NA) Group B (EUS -NA) P value
Age, y, mean (range) 38 (20–57) 39 (25–70) 0.104
Men, n (%) 32 (59.3) 25 (54.3) 0.687
Women, n (%) 22 (40.7) 21 (45.7) 0.687
Stage I sarcoidosis, n (%) 30 (55.6) 24 (52.2) 0.841
Stage II sarcoidosis, n (%) 24 (44.4) 22 (47.8) 0.841
Steroid therapy, n (%) 4 (7.4) 6 (13) 1.000
a Data of excluded patients are not included in the table.
Abbreviations: EBUS -FNA, endobronchial ultrasound fine-needle aspiration; EUS -FNA, endoscopic ultrasound fine-
-needle aspiration
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For the final analysis, data from 100 patients 
were available. Cytological or histological confir‑
mation of the diagnosis was obtained in all pa‑
tients. Minimally invasive techniques, that is, EBB, 
TBNA, TBLB, EBUS ‑FNA, and EUS ‑FNA, were suc‑
cessful in 96% of patients, and mediastinoscopy 
was only necessary in the remaining 4%.
Three patients were excluded at this stage. Two 
of them withdrew their consent to undergo me‑
diastinoscopy, and in 1 patient complete remis‑
sion of mediastinal lymphadenopathy was found 
on endosonography.
Because of the lack of diagnosis, mediastinos‑
copy was performed in 4 patients and confirmed 
sarcoidosis in all of them (FIGURE 4).
FIGURE 4 Flowchart of patients. Abbreviations: EBB, endobronchial biopsy, TBLB, transbronchial lung biopsy, TBNA, transbronchial needle 
aspiration; others, see TABLE 1
Enrollment
Patients with clinical diagnosis 
of stage I or II sarcoidosis
n = 106
Randomization 1:1
Noncaseating granuloma
Noncaseating granuloma
Noncaseating granuloma
Sarcoidosis
n = 46
Sarcoidosis
n = 9
Sarcoidosis
n = 4
EUS-FNA
n = 8
6-month follow-up
6-month 
follow-up
6-month 
follow-up
6-month follow-up
n = 0
6-month follow-up
Mediastinoscopy
n = 4
Follow-up
Analysis
Excluded
n = 3
Excluded
n = 2
+ +
+
+
− −
−
−
Excluded
n = 1
Allocation
TBNA + EBB + TBLB
bronchial lavage BACTEC
EBUS-FNA
cytological smear
BACTEC
n = 55
TBNA + EBB + TBLB
bronchail lavage BACTEC
EUS-FNA
cytological smear
BACTEC
n = 51
Sarcoidosis
n = 41
EBUS-FNA
n = 8
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techniques. For EBUS ‑FNA, sensitivity and accu‑
racy were 0.62, and for EUS ‑FNA—0.75. Combi‑
nation of EBUS ‑FNA and EUS ‑FNA had the sen‑
sitivity and accuracy of 0.8 (TABLE 2 and FIGURE 6).
The bootstrap method was used to compare 
the sensitivity and accuracy of different tests. 
Sensitivity and accuracy of each of the endosono‑
graphic techniques were significantly better than 
those of EBB + TBLB (P = 0.0072 and P = 0.0084, 
respectively) and than those of EBB + TBLB 
+ TBNA (P = 0.0112 and P = 0.0134, respectively).
The sensitivity and accuracy of the standard di‑
agnostic techniques were as follows: 0.12 and 0.12, 
respectively, for EBB; 0.42 and 0.42, respective‑
ly, for TBLB; and 0.42 and 0.44, respectively, for 
TBNA (TABLE 2 and FIGURE 5). A combination of all 
standard endoscopic techniques (ie, EBB, TBLB, 
and TBNA) allowed for the confirmation of the di‑
agnosis in 64% of the patients, with sensitivity 
and accuracy of 0.64.
The diagnostic yield of the endosonographic 
techniques was higher than that of the standard 
TABLE 2 Diagnostic yield of bioptic techniques
Test Sensitivity Accuracy
Value 95% CI Value 95% CI
EBB 0.12 0.06–0.19 0.12 0.064–0.20
TBLB 0.42 0.32–0.52 0.42 0.32–0.52
TBNA  0.42 0.16–0.69 0.44 0.14–0.69
EBB + TBLB 0.44 0.34–0.54 0.44 0.34–0.54
EBB + TBLB + TBNA 0.64 0.54–0.73 0.64 0.54–0.73
EBUS -FNA 0.62 0.49–0.74 0.62 0.49–0.74
EUS -FNA 0.75 0.61–0.85 0.75 0.61–0.85
EBUS -FNA + EUS -FNA 0.80 0.71–0.87 0.80 0.71–0.87
Abbreviations: EBB, endobronchial biopsy, TBLB, transbronchial lung biopsy, TBNA, transbronchial needle aspiration; 
others, see TABLE 1 and FIGURE 4
FIGURE 5 Diagnostic 
accuracy of standard 
bioptic techniques 
Abbreviations: see 
FIGURE 4 EBB TBLB TBNA
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techniques.2,4-8 In the present study, the diagno‑
sis of sarcoidosis was confirmed using minimally 
invasive methods in 96% of the patients, and me‑
diastinoscopy was only necessary in 4%.
An important development in the diagnosis of 
sarcoidosis is the feasibility of a reliable confirma‑
tion on the basis of cytological smear, because it 
eliminates the need for invasive procedures aimed 
at taking large samples for a histological exam‑
ination. An adequately experienced pathologist 
is crucial, and differentiation with other clinical 
entities presenting with similar granulomas is 
necessary. In the present study, all samples were 
assessed independently by 2 pathologists, and 
testing for tuberculosis was routinely performed.
It should be noted that, at the time of biopsy, 
the intensity of symptoms varied among patients. 
In most of them, biopsy was performed at a point 
where symptoms had subsided or even almost 
completely resolved. This was due to the long time 
of initial diagnostic workup from the first onset 
of symptoms, before the patients were referred 
for biopsy. This delay was underlined by Judson 
et al.10 It is mainly dependent on clinical symp‑
toms, on the basis of which general practitioners 
may suspect sarcoidosis. Judson et al10 analyzed 
The comparison of EBUS ‑FNA and EUS ‑FNA 
showed higher sensitivity and accuracy of the lat‑
ter, but the  difference did not reach the  lev‑
el of significance (P = 0.0724 and P = 0.0810, 
respectively).
The BACTEC examination of bronchial lavage 
or lymph node samples did not reveal tuberculo‑
sis in any of the patients.
DISCUSSION Cytological or histological confir‑
mation of sarcoidosis is an important element 
of diagnosis. For this purpose, EBB and TBLB, 
and also in many centers TBNA, have been used. 
The widespread use of the endosonographic tech‑
niques—EBUS and EUS—for lung cancer stag‑
ing4-8 has given rise to an interest in applying 
them also to cover the diagnosis of sarcoidosis.9 
Our study is novel in that it was based on the as‑
sessment of modern, minimally invasive endo‑
sonographic techniques and pathological exami‑
nation of cytological smears rather than histolog‑
ical specimens. The main advantage of the endo‑
scopic techniques is that they save patients from 
invasive surgical biopsy via mediastinoscopy. Lit‑
erature data show a trend towards replacement 
of mediastinoscopy by the minimally invasive 
EBUS-FNA EUS-FNA EBUS-FNA+EUS-FNA
Ac
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cy
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80
74.55
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FIGURE 6 Diagnostic 
accuracy of 
endosonographic 
techniques 
Abbreviations: see 
TABLE 1
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for EBUS ‑FNA (93%), but the number of patients 
in this study was very small (n = 15).19 
Experience is particularly important in each 
procedure. In the case of endosonograhic tech‑
niques, experience of the endoscopic team as well 
as of pathologists in cytology smear assessment 
is necessary. In the study of Szlubowski et al21 in 
a group of 41 patients with suspected sarcoidosis, 
the diagnosis was confirmed in 85.7% of the cases. 
In the study of Gnass et al23 (performed with par‑
ticipation of our team), the sensitivity and accu‑
racy of EBUS ‑FNA were 0.79 and 0.8, respectively, 
and of EUS ‑FNA—0.88 and 0.89, respectively. In 
the study of Szlubowski et al21 the same technique 
was used, but a different pathology team assessed 
cytological smears. In the study of Gnass et al,23 
as in the present study, patients were diagnosed 
in the same endoscopy unit. The study of Gnass et 
al23 was designed and started at the end of enroll‑
ing patients to this study. The inclusion and exclu‑
sion criteria were similar. Patients in the study of 
Gnass et al23 were referred from the Departments 
of Pulmonology at John Paul II Hospital (a differ‑
ent group of patients). Cytological smears were 
assessed in the same Department of Pathology. 
The study of Gnass et al23 had a different design 
but assessed mainly endosonographic techniques. 
The EBUS/EUS has been used in this endoscopy 
unit since 2008. During the years from 2009 to 
2013 (first study, October 2009 – May 2012, de‑
scribed in this publication; then, January 2012 – 
February 2013, described in the study of Gnass et 
al23), the endoscopic and pathology teams gained 
more experience in the technique, which result‑
ed in much higher sensitivity of the procedures.
In a prospective study by Tournoy et al,20 en‑
dosonographic techniques confirmed the diag‑
nosis of sarcoidosis in an additional 59% of pa‑
tients in whom the results of the standard endo‑
scopic techniques had been negative.
The standard endoscopic techniques (ie, EBB, 
TBLB, and TBNA) were compared with EBUS ‑FNA 
by Navani et al).24 The sensitivity of these meth‑
ods were 35% and 85%, respectively. Von Bar‑
theld et al18 conducted a prospective study in‑
cluding 101 patients with suspected sarcoidosis in 
whom standard endoscopic techniques had failed 
to confirm the diagnosis in 55%. The sensitivity 
of EUS ‑FNA was 92% in stage I and 77% in stage 
II sarcoidosis. The authors suggested that 4 nee‑
dle passes are optimal for a reliable diagnosis.18
In the present study, EBB enabled the confir‑
mation of diagnosis only in 12% of the patients. 
It has been reported that its diagnostic yield is 
higher if there are bronchoscopically detectable 
lesions of the bronchial mucosa. Armstrong et 
al,25 in a group of 101 patients with suspected 
sarcoidosis, found sensitivity of EBB to be 58% 
in stage I and 62% in stage II sarcoidosis. The au‑
thors also noted that the rate of diagnosis was 
91% if there were mucosal lesions, but only 37% 
in case of normal mucosa. Sensitivity similar to 
the present study (0.14) was reported by Ziora et 
al26 in a study which included 112 patients.
data of 189 patients. Sarcoidosis was diagnosed or 
suspected during the first visit in only 15%, and 
a median of 4 visits was needed to make the final 
diagnosis in 79% of them. The time since the on‑
set of symptoms was less than 3 months in 50% of 
the patients and less than 6 months in 68%. This 
time was longer when only pulmonary symptoms 
were present and shorter if skin signs occurred.
Fifty patients analyzed in the present study had 
initially been diagnosed in pulmonology depart‑
ments of other hospitals. In 11 patients, cortico‑
steroid therapy had been initiated before the di‑
agnostic workup was completed, with a subse‑
quent remission of symptoms. This symptomat‑
ic improvement was associated with remission 
of pulmonary lesions and, more importantly, of 
mediastinal lymphadenopathy.
In our study, endosonography confirmed that 
the paratracheal lymphadenopathy subsided 
first, with subcarinal and hilar nodes being still 
enlarged. As the latter are easily accessible by 
endosonography ‑guided biopsy, this pattern of 
remission favors the minimally invasive tech‑
niques over mediastinoscopy.
In our opinion, the possibility of monitoring 
the size of lymph nodes is an important advan‑
tage of endosonography, reducing the need for 
computed tomography and, therefore, patients’ 
exposure to radiation. It should be taken into 
consideration and confirmed in further studies.
The diagnostic modality that has traditional‑
ly been favored by pulmonologists is EBB, with 
TBLB and TBNA used by some endoscopists.9,11 
In the present study, EBB, TBLB, and TBNA were 
considered the standard techniques, which is con‑
sistent with other studies.1,9 With these tech‑
niques, the diagnosis of sarcoidosis was confirmed 
in 64% of the patients. Adding TBNA to the com‑
bination of EBB + TBLB increased the sensitivity 
by 20%. This observation supports using TBNA 
at the initial stage of the diagnostic workup. It 
is also important that TBNA is technically sim‑
ple and does not require expensive equipment.
According to Morales et al,12 who analyzed 51 
patients, adding TBNA to TBLB increased the rate 
of diagnosis from 60% to 83% in stage I sarcoid‑
osis and from 76% to 86% in stage II sarcoidosis.
In the present study, the sensitivity and accu‑
racy of EBUS ‑FNA were 0.62 and 0.62, respec‑
tively, and of EUS ‑FNA—0.75 and 0.75, respec‑
tively, while the combination of EBUS ‑FNA and 
EUS ‑FNA allowed for confirmation of the diag‑
nosis in 80% of the patients. In a meta ‑analysis 
published in 2012, including data from 553 pa‑
tients taken from 15 studies, the accuracy of en‑
dosonographic techniques was 54% to 93%.13 
The high sensitivity of endosonographic tech‑
niques (71%–100%) has been confirmed by oth‑
er authors, and these numbers are consistent 
with the results of the present study.2,6,8,14-21 In 
a randomized study by Tremblay et al,22 the dif‑
ference in sensitivity between EBUS ‑FNA and 
TBNA was 29.5% in favor of the former. In one 
study, the sensitivity of TBNA was the same as 
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be the methods of choice in patients suspected 
of sarcoidosis stages I and II. A combination of 
standard endoscopic methods, especially TBNA 
and TBLB, increases the yield of confirmation of 
sarcoidosis.
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